SanofiSNYNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank86
3Y CAGR-2.1%
5Y CAGR-6.6%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-2.1%/yr
vs +10.1%/yr prior
5Y CAGR
-6.6%/yr
Recent acceleration
Acceleration
-12.2pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$12.68B+14.9%
2024$11.03B-3.1%
2023$11.39B-15.7%
2022$13.51B+17.1%
2021$11.54B-35.5%
2020$17.88B+67.7%
2019$10.66B+16.2%
2018$9.18B-4.8%
2017$9.64B-2.7%
2016$9.90B-